Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology ...

Enterprises seeking to make good on the promise of agentic AI will need a platform for building, wrangling, and monitoring AI agents in purposeful workflows. In this quickly evolving space, myriad ...

In Part 4, Carolyn Krause learns more about the processes behind BWXT and LIS Technologies, which will be part of the nuclear hub.